As part of the settlement, CVS admitted and accepted responsibility for certain conduct alleged by the government, including ...
Harrow, Inc. has secured a key win as CVS’s pharmacy benefit manager replaced Xiidra with Harrow’s dry eye drug Vevye on its Tier 1 formulary, and the company recently presented at BTIG Ophthalmology ...
Dr. Siavash Ghoreishi, who is fighting for visitation with his granddaughter, prescribed more medicine to Shahrzad “Sherry” ...
Wednesday's mistrial motion, filed by Walmart, Walgreens and CVS, cites the extraordinary length of jury deliberations and ...
Thanksgiving 2025: With banks, post offices and financial markets scheduled to remain closed on Thursday, Nov. 27, attention ...
CVS settles insulin dispensing case for $38M over improper billing to Medicare, Medicaid and federal health programs from 2010 to 2020.
This milestone event will highlight the newly completed residential spaces inside the Prichard building and showcase the next ...
By Jonathan Stempel NEW YORK, Dec 2 (Reuters) - CVS Health will pay $37.76 million to settle allegations it dispensed too ...
This milestone event will highlight the newly completed residential spaces inside the Prichard building and showcase the next ...
MiBolsilloColombia on MSN
CVS agrees to pay $37.8 million in record insulin pen fraud case
A record $37.8 million settlement closes a decade-long case alleging that CVS overbilled government health programs by ...
CVS has settled a lawsuit for $37.76 million over claims of over-dispensing insulin pens and fraudulent billing.
As Dr. Siavash Ghoreishi fights for visitation with his granddaughter, he defends the prescriptions he wrote for Shahrzad ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results